Eps8 peptide 327
Eps8 peptide 327 is an HLA-A*2402-restricted peptide antigen derived from Eps8 protein. Eps8 peptide 327 has potent antitumor activity with significant cytotoxicity. Eps8 peptide 327 effectively inhibits cancer cells proliferation, induces apoptosis and disrupts EGFR signal pathway by inhibiting downstream signals (such as IL-2, TNF-α and IFN-γ) expression and the Eps8/EGFR interaction. Eps8 peptide 327 significantly inhibits tumor growth in HT-29 xenograft mcie models.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1988684-26-9
- Formel: C56H77N11O15S
- Molecular Weight:1176.34
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
IL-2 |
Chemical Information
-
CAS. Nr. 1988684-26-9
-
Molecular Weight 1176.34
-
Formel C56H77N11O15S
-
Synonyms
Eps8(327-335)
-
Sequence
Glu-Phe-Leu-Asp-Cys-Phe-Gln-Lys-Phe
-
Sequence Shortening
EFLDCFQKF
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Eps8 peptide 327
- 1988684-26-9
- Eps8(327-335)
- EGFR
- IFNAR
- Interleukin Related
- TNF Receptor
- Complement System
- Apoptosis
- Epidermal growth factor receptor
- ErbB-1
- HER1
- Interferon-α/β receptor
- Interferon-alpha/beta receptor
- IL
- Tumor Necrosis Factor Receptor
- TNFR
- HLA-A*2402
- Restricted peptide antigen
- Eps8
- Antitumor
- A549 cells
- Colo320 cells
- HepG2 cells
- HT-29 cells
- HT-29 xenograft mcie models
- Inhibitor
- inhibitor
- inhibit